Why Is Buffett Buying Verisign?
Warren Buffett has spent 2024 stockpiling cash, even going so…
Sell
43
FCX Quote, Financials, Valuation and Earnings
Last price:
$37.99
Seasonality move
:
7.93%
Day range:
$38.56 - $39.18
52-week range:
$36.26 - $55.24
Dividend yield:
1.54%
P/E ratio:
28.37x
P/S ratio:
2.19x
P/B ratio:
3.18x
Volume:
7.8M
Avg. volume:
11.2M
1-year change:
-10.05%
Market cap:
$55.8B
Revenue:
$22.9B
EPS (TTM):
$1.37
Analysts' Opinion
-
Consensus RatingFreeport-McMoRan has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $54.48, Freeport-McMoRan has an estimated upside of 36.17% from its current price of $38.86.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $43.08 representing 100% downside risk from its current price of $38.86.
Fair Value
-
According to the consensus of 15 analysts, Freeport-McMoRan has 36.17% upside to fair value with a price target of $54.48 per share.
FCX vs. S&P 500
-
Over the past 5 trading days, Freeport-McMoRan has overperformed the S&P 500 by 0.94% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Freeport-McMoRan does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Freeport-McMoRan has grown year-over-year revenues for 6 quarters straight. In the most recent quarter Freeport-McMoRan reported revenues of $6.8B.
Earnings Growth
-
Freeport-McMoRan has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Freeport-McMoRan reported earnings per share of $0.36.
Enterprise value:
71.8B
EV / Invested capital:
1.86x
Price / LTM sales:
2.19x
EV / EBIT:
9.28x
EV / Revenue:
2.80x
PEG ratio (5yr expected):
--
EV / Free cash flow:
34.00x
Price / Operating cash flow:
26.56x
Enterprise value / EBITDA:
7.16x
Gross Profit (TTM):
$8.2B
Return On Assets:
3.73%
Net Income Margin (TTM):
7.81%
Return On Equity:
7.17%
Return On Invested Capital:
5.36%
Operating Margin:
28.54%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $23.2B | $22.7B | $25.6B | $5.8B | $6.8B | |
| Gross Profit | $8.4B | $6.9B | $8.2B | $1.7B | $2.1B | |
| Operating Income | $7.8B | $6B | $7.3B | $1.5B | $1.9B | |
| EBITDA | $9.8B | $8.4B | $10B | $2.1B | $2.6B | |
| Diluted EPS | $2.63 | $1.48 | $1.37 | $0.31 | $0.36 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $8.1B | $13.8B | $15.4B | $14.1B | $14.5B | |
| Total Assets | $41.1B | $46.9B | $49.9B | $51.6B | $55.4B | |
| Current Liabilities | $3.1B | $5.5B | $6B | $4.9B | $6.2B | |
| Total Liabilities | $23.5B | $24.4B | $25.7B | $25B | $26.5B | |
| Total Equity | $17.6B | $22.5B | $24.2B | $26.7B | $28.9B | |
| Total Debt | $10B | $9.7B | $10.7B | $9.4B | $9.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $6.4B | $5B | $7B | $1.2B | $1.9B | |
| Cash From Investing | -$3.1B | -$4.6B | -$5.2B | -$1.2B | -$1.4B | |
| Cash From Financing | -$2.3B | -$2.7B | -$2.2B | -$414M | -$646M | |
| Free Cash Flow | $3.2B | $519M | $2.1B | $58M | $673M | |
FCX
Sector
Market Cap
$55.8B
$18.5M
Price % of 52-Week High
70.35%
57.9%
Dividend Yield
1.54%
0%
Shareholder Yield
--
1.61%
1-Year Price Total Return
-10.05%
-19.21%
Beta (5-Year)
1.860
1.063
Dividend yield:
1.54%
Annualized payout:
$0.60
Payout ratio:
43.19%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$39.12
200-day SMA
Sell
Level
$46.69
Bollinger Bands (100)
Sell
Level
41.14 - 47.7
Chaikin Money Flow
Buy
Level
776.9M
20-day SMA
Sell
Level
$41.32
Relative Strength Index (RSI14)
Sell
Level
32.03
ADX Line
Sell
Level
27.33
Williams %R
Buy
Level
-83.1334
50-day SMA
Sell
Level
$43.87
MACD (12, 26)
Sell
Level
-1.50
25-day Aroon Oscillator
Sell
Level
-48
On Balance Volume
Neutral
Level
1.6B
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.4335)
Sell
CA Score
(Annual)
Level (-0.5913)
Buy
Beneish M-Score
(Annual)
Level (-2.7358)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-1.468)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Freeport-McMoRan owns stakes in 10 copper mines, led by its 49% ownership of the Grasberg copper and gold operations in Indonesia, 55% of the Cerro Verde mine in Peru, and 72% of Morenci in Arizona. It sold around 1.2 million metric tons of copper (its share) in 2023, making it the one of the world’s largest copper miners by volume. It also sold about 900,000 ounces of gold, mostly from Grasberg, and 70 million pounds of molybdenum. About 75% of 2023 revenue was from copper, with a further 15% from gold and about 10% from molybdenum. It had about 25 years of copper reserves at end December 2023. we expect it to sell similar amounts of copper midcycle in 2028, though we expect gold volumes to decline to about 700,000 ounces then due to falling production at Grasberg.
Stock Forecast FAQ
In the current month, FCX has received 8 Buy ratings 7 Hold ratings, and 0 Sell ratings. The FCX average analyst price target in the past 3 months is $54.48.
-
Where Will Freeport-McMoRan Stock Be In 1 Year?
According to analysts, the consensus estimate is that Freeport-McMoRan share price will rise to $54.48 per share over the next 12 months.
-
What Do Analysts Say About Freeport-McMoRan?
Analysts are divided on their view about Freeport-McMoRan share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Freeport-McMoRan is a Sell and believe this share price will drop from its current level to $43.08.
-
What Is Freeport-McMoRan's Price Target?
The price target for Freeport-McMoRan over the next 1-year time period is forecast to be $54.48 according to 15 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is FCX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Freeport-McMoRan is a Buy. 8 of 15 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of FCX?
You can purchase shares of Freeport-McMoRan via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Freeport-McMoRan shares.
-
What Is The Freeport-McMoRan Share Price Today?
Freeport-McMoRan was last trading at $37.99 per share. This represents the most recent stock quote for Freeport-McMoRan. Yesterday, Freeport-McMoRan closed at $38.86 per share.
-
How To Buy Freeport-McMoRan Stock Online?
In order to purchase Freeport-McMoRan stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Microsoft an Undervalued Growth Stock to Buy?
Tech giant Microsoft (NASDAQ:MSFT) has been one of the biggest…
Will Tesla Go Up or Down in 2025?
The last few months have been exciting for Tesla and…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 30
Lemonade [LMND] is down 2.03% over the past day.
Buy
63
SMLR alert for Dec 30
Semler Scientific [SMLR] is down 11.08% over the past day.
Sell
39
DOGZ alert for Dec 30
Dogness (International) [DOGZ] is down 3% over the past day.
